Literature DB >> 14570927

Oligomerization and regulated proteolytic processing of angiopoietin-like protein 4.

Hongfei Ge1, Guoqing Yang, Lu Huang, Daniel L Motola, Tiffany Pourbahrami, Cai Li.   

Abstract

Angiopoietin-like protein 4 (Angptl4) is a recently identified circulating protein expressed primarily in adipose tissue and liver. Also known as peroxisome proliferator-activated receptor (PPAR)-gamma angiopoietin-related, fasting induced adipose factor, and hepatic fibrinogen/angiopoietin-related protein, recombinant Angptl4 causes increase of plasma very low density lipoprotein levels by inhibition of lipoprotein lipase activity. Similar to angiopoietins and other angiopoietin-like proteins, Angptl4 contains an amino-terminal coiled-coil domain and a carboxyl-terminal fibrinogen-like domain. We report here that Angptl4 is evolutionarily conserved among several mammalian species and that full-length Angptl4 protein is an oligomer containing intermolecular disulfide bonds. Oligomerized Angptl4 undergoes proteolytic processing to release its carboxyl fibrinogen-like domain, which circulates as a monomer. Angptl4's N-terminal coiled-coil domain mediates its oligomerization, which by itself is sufficient to form higher order oligomeric structure. Adenovirus-mediated overexpression of Angptl4 in 293 cells shows that conversion of full-length, oligomerized Angptl4 is mediated by a cell-associated protease activity induced by serum. These findings demonstrate a novel property of angiopoietin-like proteins and suggest that oligomerization and proteolytic processing of Angptl4 may regulate its biological activities in vivo.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14570927     DOI: 10.1074/jbc.M307583200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  64 in total

1.  Fatty acids bind tightly to the N-terminal domain of angiopoietin-like protein 4 and modulate its interaction with lipoprotein lipase.

Authors:  Terje Robal; Mikael Larsson; Miina Martin; Gunilla Olivecrona; Aivar Lookene
Journal:  J Biol Chem       Date:  2012-07-07       Impact factor: 5.157

Review 2.  Bugging the intestinal response to radiation.

Authors:  Ralph R Weichselbaum
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-13       Impact factor: 11.205

Review 3.  ANGPTL4 in Metabolic and Cardiovascular Disease.

Authors:  Binod Aryal; Nathan L Price; Yajaira Suarez; Carlos Fernández-Hernando
Journal:  Trends Mol Med       Date:  2019-06-21       Impact factor: 11.951

Review 4.  Role of Angptl4 in vascular permeability and inflammation.

Authors:  Liang Guo; Shao-Ying Li; Fu-Yun Ji; Yun-Feng Zhao; Yu Zhong; Xue-Jun Lv; Xue-Ling Wu; Gui-Sheng Qian
Journal:  Inflamm Res       Date:  2013-10-31       Impact factor: 4.575

5.  The Semaphorin 4D-Plexin-B1-RhoA signaling axis recruits pericytes and regulates vascular permeability through endothelial production of PDGF-B and ANGPTL4.

Authors:  Hua Zhou; Ying-Hua Yang; John R Basile
Journal:  Angiogenesis       Date:  2013-10-10       Impact factor: 9.596

6.  Extracellular matrix-bound angiopoietin-like 4 inhibits endothelial cell adhesion, migration, and sprouting and alters actin cytoskeleton.

Authors:  Aurélie Cazes; Ariane Galaup; Clémence Chomel; Marine Bignon; Nicolas Bréchot; Sébastien Le Jan; Holger Weber; Pierre Corvol; Laurent Muller; Stéphane Germain; Catherine Monnot
Journal:  Circ Res       Date:  2006-10-26       Impact factor: 17.367

7.  Inhibition of cardiac lipoprotein utilization by transgenic overexpression of Angptl4 in the heart.

Authors:  Xinxin Yu; Shawn C Burgess; Hongfei Ge; Kenny K Wong; R Haris Nassem; Daniel J Garry; A Dean Sherry; Craig R Malloy; Joel P Berger; Cai Li
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-19       Impact factor: 11.205

8.  Angiopoietin-like protein 4 decreases blood glucose and improves glucose tolerance but induces hyperlipidemia and hepatic steatosis in mice.

Authors:  Aimin Xu; Michael C Lam; Kok Weng Chan; Yu Wang; Jialiang Zhang; Ruby L C Hoo; Jian Yu Xu; Baoying Chen; Wing-Sun Chow; Annette W K Tso; Karen S L Lam
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-18       Impact factor: 11.205

9.  Rare loss-of-function mutations in ANGPTL family members contribute to plasma triglyceride levels in humans.

Authors:  Stefano Romeo; Wu Yin; Julia Kozlitina; Len A Pennacchio; Eric Boerwinkle; Helen H Hobbs; Jonathan C Cohen
Journal:  J Clin Invest       Date:  2008-12-15       Impact factor: 14.808

10.  Mice lacking ANGPTL8 (Betatrophin) manifest disrupted triglyceride metabolism without impaired glucose homeostasis.

Authors:  Yan Wang; Fabiana Quagliarini; Viktoria Gusarova; Jesper Gromada; David M Valenzuela; Jonathan C Cohen; Helen H Hobbs
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-16       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.